At Oxford Nanopore Technologies, we're transforming how the world analyses DNA and RNA. Our unique nanopore sequencing technology enables real-time analysis, from handheld devices to population-scale sequencing, helping researchers and clinicians unlock insights faster than ever before.
Our mission is simple but ambitious: to enable the analysis of any living thing, by anyone, anywhere.
We're looking for an experienced Technical Writer to join our Product Management team and play a key role in delivering clear, compliant and customer-focused documentation for our innovative sequencing devices.
As Technical Writer, you'll take ownership of the documentation portfolio for Oxford Nanopore's sequencing devices throughout the product lifecycle. This role sits within a regulated, change-controlled environment and is responsible for producing and maintaining documentation that supports both customers and regulatory compliance activities across our research-use-only, regulated and diagnostic products.
Working closely with Engineering, Product Management, Quality, Regulatory Affairs, R&D and Commercial teams, you'll ensure documentation is technically accurate, compliant with relevant quality processes and delivered in line with product release timelines. You'll play a critical role in supporting both customer success and external compliance requirements, requiring exceptional attention to detail and a strong understanding of controlled documentation practices.
This is an excellent opportunity for someone who enjoys working at the intersection of science, technology and communication and wants to make a tangible impact on cutting-edge products used around the world.
You'll be responsible for creating, maintaining and continuously improving a range of technical documentation, including:
In addition, you'll:
We're looking for someone with a strong technical background and experience producing documentation for complex products within a regulated or quality-managed environment. You'll be passionate about creating high-quality documentation that supports both customers and compliance requirements.
Why Oxford Nanopore?
You'll join a pioneering company where innovation, collaboration and scientific discovery are at the heart of everything we do. You'll have the opportunity to work with industry-leading technology, contribute to products that are advancing research and healthcare globally, and help shape how we communicate complex technology to audiences around the world.
If you're passionate about technical communication and want to help make breakthrough sequencing technology accessible to customers worldwide, we'd love to hear from you.
Apply now and join us in redefining what's possible in genomics.
Please note that no terminology in this advert is intended to discriminate on the grounds of a person's gender, marital status, race, religion, colour, age, disability or sexual orientation. Every candidate will be assessed only in accordance with their merits, qualifications and abilities to perform the duties of the job.
#LI-LH1
#LI-hybrid
Oxford Nanopore Technologies: Our goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The company has developed a new generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing, and the technology is in development for the analysis of other types of molecules including proteins. The technology is used to understand and characterise the biology of humans and diseases such as cancer, plants, animals, bacteria, viruses, and whole environments. With a thriving culture of ambition and strong innovation goals, Oxford Nanopore is a UK headquartered company with global operations and customers in more than 125 countries.
Our goal is to enable the analysis of anything, anywhere, by anyone.
We have developed the world’s first and only nanopore DNA and RNA sequencing platform. It’s a new generation of sequencing technology — the only one to offer: scalability to portable or ultra-high throughput formats, real-time data delivery, and the ability to elucidate rich biological data.
We are aiming to disrupt the way that biological analyses are currently performed, and open up new applications that have a profound, positive impact on society.
Our devices offer real-time analysis, for rapid insights, in fully scalable formats — from pocket to population scale — and the technology is being used in more than 100 countries worldwide.
Founded in 2005 as a spin-out from the University of Oxford, the company now employs more than 600 people from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialisation. The management team, led by CEO Dr Gordon Sanghera, has a track record of delivering disruptive technologies to the market.
